Birabaharan M, Hill E, Begur M, Kaelber DC, et al. Cardiovascular outcomes after tixagevimab and cilgavimab use for pre-exposure prophylaxis against COVID-19: a population-based propensity-matched cohort study. Clin Infect Dis 2022 Nov 16. pii: 6830248. doi: 10.1093.
PMID: 36380460